SCHEMBL9936930

SCHEMBL9936930

O=C(Nc1cccnc1)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.41
SMPD3 Q9NY59 1/20 0.41
ROCK2 O75116 1/20 0.40
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
TP53 P04637 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
KMT2A Q03164 3/20 0.38
PKM P14618 1/20 0.38
PORCN Q9H237 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29871537 0.77 GAA (0.43) MAPTKDM4ETP53SMN1; SMN2POLB
SCHEMBL9938286 0.76 ACHE (0.38) ACHEKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL9938270 0.76 ACHE (0.40) ACHERAB9A
SCHEMBL9937653 0.75 KMT2A (0.37) ROCK2MAPTKDM4EPOLBHPGD
SCHEMBL668901 0.75 CA12 (0.41) MAPTKDM4ETP53SMN1; SMN2POLB
SCHEMBL996026 0.75 CA12 (0.41) MAPTKDM4ETP53SMN1; SMN2POLB
SCHEMBL669403 0.73 KMT2A (0.55) MAPTKDM4EPOLBHSD17B10TDP1
SCHEMBL19253296 0.73 NCEH1 (0.30) MAPTSMN1; SMN2KMT2AMEN1
SCHEMBL26104675 0.73 MEN1 (0.30) MAPTSMN1; SMN2KMT2AMEN1
SCHEMBL25278087 0.72 DPP8 (0.34) ROCK2MAPTSMN1; SMN2TDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed